Journal Articles Conference Presentations Book Chapters Public Presentations

Gene therapy progress and prospects: cystic fibrosis.

Griesenbach U, Ferrari S, Geddes DM, Alton EW

Gene Therapy

Gene Ther. 2002 Oct;9(20):1344-50.

 Download the Manuscript

Print this page

Since the cloning of the cystic fibrosis gene (CFTR) in 1989, 18 clinical trials have been carried out, including five in the 2 years reviewed here. Most trials demonstrated proof-of-principle for gene transfer to the airway. However, gene transfer efficiency with each of the three gene transfer agents (adenovirus (Ad), adeno-associated virus 2 (AAV2) and cationic liposomes) was low, and most likely insufficient to achieve clinical benefit. Here, we will review the clinical and pre-clinical progress for the last 2 years (2000-2001) and briefly speculate on future prospects for the next 2 in CF gene therapy.

Go Back to Publications     View on Pubmed (12364999)    View on Google Scholar


 

Other Publications by these authors
Self-reactive CFTR T cells in humans: implications for gene therapy.
Calcedo R et al. Human Gene Therapy. Clinical Development (2013) Expert opinion in biological therapy: update on developments in lung gene transfer.
Griesenbach U et al. Expert Opinion On Biological Therapy (2013) Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.
Griesenbach U et al. American Journal Of Respiratory And Critical Care Medicine (2012) Assessment of the nuclear pore dilating agent trans-cyclohexane-1,2-diol in differentiated airway epithelium.
Griesenbach U et al. The Journal Of Gene Medicine (2012) Progress in gene and cell therapy for cystic fibrosis lung disease.
Griesenbach U et al. Current Pharmaceutical Design (2012) Magnetic nanoparticles as gene delivery agents: enhanced transfection in the presence of oscillating magnet arrays.
McBain SC et al. Nanotechnology (2008)